Log in

Laboratory Corp. of America Stock Price, Forecast & Analysis (NYSE:LH)

$165.83
-2.58 (-1.53 %)
(As of 11/12/2019 06:24 AM ET)
Today's Range
$165.43
Now: $165.83
$167.97
50-Day Range
$162.44
MA: $166.86
$172.69
52-Week Range
$119.38
Now: $165.83
$178.44
Volume319,875 shs
Average Volume543,067 shs
Market Capitalization$16.10 billion
P/E Ratio15.05
Dividend YieldN/A
Beta1.01
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.33 billion
Cash Flow$16.42 per share
Book Value$69.09 per share

Profitability

Net Income$883.70 million

Miscellaneous

Employees61,000
Market Cap$16.10 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) announced its quarterly earnings results on Thursday, October, 24th. The medical research company reported $2.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.85 by $0.05. The medical research company had revenue of $2.93 billion for the quarter, compared to analysts' expectations of $2.91 billion. Laboratory Corp. of America had a net margin of 6.63% and a return on equity of 15.33%. Laboratory Corp. of America's quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.74 earnings per share. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America issued an update on its FY19 earnings guidance on Thursday, October, 24th. The company provided earnings per share guidance of $11.20-$11.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.27. The company issued revenue guidance of $11.5-$11.56 billion, compared to the consensus revenue estimate of $11.48 billion.

What price target have analysts set for LH?

16 analysts have issued 12-month price objectives for Laboratory Corp. of America's stock. Their forecasts range from $164.00 to $220.00. On average, they anticipate Laboratory Corp. of America's share price to reach $185.89 in the next year. This suggests a possible upside of 12.1% from the stock's current price. View Analyst Price Targets for Laboratory Corp. of America.

What is the consensus analysts' recommendation for Laboratory Corp. of America?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 1 sell rating, 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

News articles about LH stock have been trending very negative on Tuesday, according to InfoTrie. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Laboratory Corp. of America earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned news headlines about the medical research company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Laboratory Corp. of America.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Micron Technology (MU), Amgen (AMGN), Endologix (ELGX), NVIDIA (NVDA), Allergan (AGN), Intel (INTC), Chipotle Mexican Grill (CMG) and Cisco Systems (CSCO).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by a variety of of institutional and retail investors. Top institutional investors include California Public Employees Retirement System (0.82%), Sumitomo Mitsui Trust Holdings Inc. (0.55%), Calamos Advisors LLC (0.55%), Veritas Investment Management LLP (0.53%), Beck Mack & Oliver LLC (0.52%) and Teacher Retirement System of Texas (0.41%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Der Vaart Sandra D Van, Edward T Dodson, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Global Thematic Partners LLC, Banco Santander S.A., First Trust Advisors LP, Assenagon Asset Management S.A., Fjarde AP Fonden Fourth Swedish National Pension Fund, Russell Investments Group Ltd. and First Quadrant L P CA. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, California Public Employees Retirement System, Teacher Retirement System of Texas, Zurcher Kantonalbank Zurich Cantonalbank, Sumitomo Mitsui Trust Holdings Inc., State of Alaska Department of Revenue, Great Lakes Advisors LLC and Veritas Investment Management LLP. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $165.83.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $16.10 billion and generates $11.33 billion in revenue each year. The medical research company earns $883.70 million in net income (profit) each year or $11.02 on an earnings per share basis. Laboratory Corp. of America employs 61,000 workers across the globe.View Additional Information About Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  477 (Vote Outperform)
Underperform Votes:  517 (Vote Underperform)
Total Votes:  994
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel